APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Asthma and COPD

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs for Asthma and COPD Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchDrugs for Asthma and COPD Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Asthma and COPD Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Drugs for Asthma and COPD Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Asthma and COPD Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Asthma and COPD Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Drugs for Asthma and COPD market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drugs for Asthma and COPD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs for Asthma and COPD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Asthma and COPD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs for Asthma and COPD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs for Asthma and COPD include GSK, Teva, Novartis, Merck, Mylan, Roche, AstraZeneca, Vertex and Sumitomo Dainippon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drugs for Asthma and COPD market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs for Asthma and COPD and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs for Asthma and COPD revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drugs for Asthma and COPD market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs for Asthma and COPD Segment by Company

GSK

Teva

Novartis

Merck

Mylan

Roche

AstraZeneca

Vertex

Sumitomo Dainippon

Chiesi

Boehringer Ingelheim

Beximco

Drugs for Asthma and COPD Segment by Type

Inhalable & Nasal Spray

Oral

Others

Drugs for Asthma and COPD Segment by Application

Asthma

COPD

Drugs for Asthma and COPD Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Asthma and COPD market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Asthma and COPD and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Asthma and COPD.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs for Asthma and COPD in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Asthma and COPD industry.

Chapter 3: Detailed analysis of Drugs for Asthma and COPD companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Asthma and COPDrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Inhalable & Nasal Spray Table 3. Key Players of Oral Table 4. Key Players of Others Table 4. Global Drugs for Asthma and COPD Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Asthma Table 6. Key Players of COPD Table 7. Global Drugs for Asthma and COPD Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Drugs for Asthma and COPD Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Drugs for Asthma and COPD Market Share by Region (2021-2026) Table 10. Global Drugs for Asthma and COPD Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Drugs for Asthma and COPD Market Share by Region (2027-2032) Table 12. Drugs for Asthma and COPD Industry Trends Table 13. Drugs for Asthma and COPD Industry Drivers Table 14. Drugs for Asthma and COPD Industry Opportunities and Challenges Table 15. Drugs for Asthma and COPD Industry Restraints Table 16. Global Drugs for Asthma and COPD Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Drugs for Asthma and COPD Revenue Market Share by Company (2021-2026) Table 18. Global Drugs for Asthma and COPD Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Drugs for Asthma and COPD Key Company Head Office and Area Served Table 20. Global Drugs for Asthma and COPD Company, Product Type & Application Table 21. Global Drugs for Asthma and COPD Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Drugs for Asthma and COPD by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Drugs for Asthma and COPD Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Drugs for Asthma and COPD Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Drugs for Asthma and COPD Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Drugs for Asthma and COPD Revenue Market Share by Type (2021-2026) Table 28. Global Drugs for Asthma and COPD Revenue Market Share by Type (2027-2032) Table 29. Global Drugs for Asthma and COPD Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Drugs for Asthma and COPD Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Drugs for Asthma and COPD Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Drugs for Asthma and COPD Revenue Market Share by Application (2021-2026) Table 33. Global Drugs for Asthma and COPD Revenue Market Share by Application (2027-2032) Table 34. GSK Company Information Table 35. GSK Business Overview Table 36. GSK Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. GSK Drugs for Asthma and COPD Product Portfolio Table 38. GSK Recent Development Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Drugs for Asthma and COPD Product Portfolio Table 43. Teva Recent Development Table 44. Novartis Company Information Table 45. Novartis Business Overview Table 46. Novartis Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Novartis Drugs for Asthma and COPD Product Portfolio Table 48. Novartis Recent Development Table 49. Merck Company Information Table 50. Merck Business Overview Table 51. Merck Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Merck Drugs for Asthma and COPD Product Portfolio Table 53. Merck Recent Development Table 54. Mylan Company Information Table 55. Mylan Business Overview Table 56. Mylan Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Mylan Drugs for Asthma and COPD Product Portfolio Table 58. Mylan Recent Development Table 59. Roche Company Information Table 60. Roche Business Overview Table 61. Roche Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Roche Drugs for Asthma and COPD Product Portfolio Table 63. Roche Recent Development Table 64. AstraZeneca Company Information Table 65. AstraZeneca Business Overview Table 66. AstraZeneca Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AstraZeneca Drugs for Asthma and COPD Product Portfolio Table 68. AstraZeneca Recent Development Table 69. Vertex Company Information Table 70. Vertex Business Overview Table 71. Vertex Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Vertex Drugs for Asthma and COPD Product Portfolio Table 73. Vertex Recent Development Table 74. Sumitomo Dainippon Company Information Table 75. Sumitomo Dainippon Business Overview Table 76. Sumitomo Dainippon Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Sumitomo Dainippon Drugs for Asthma and COPD Product Portfolio Table 78. Sumitomo Dainippon Recent Development Table 79. Chiesi Company Information Table 80. Chiesi Business Overview Table 81. Chiesi Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Chiesi Drugs for Asthma and COPD Product Portfolio Table 83. Chiesi Recent Development Table 84. Boehringer Ingelheim Company Information Table 85. Boehringer Ingelheim Business Overview Table 86. Boehringer Ingelheim Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Boehringer Ingelheim Drugs for Asthma and COPD Product Portfolio Table 88. Boehringer Ingelheim Recent Development Table 89. Beximco Company Information Table 90. Beximco Business Overview Table 91. Beximco Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Beximco Drugs for Asthma and COPD Product Portfolio Table 93. Beximco Recent Development Table 94. North America Drugs for Asthma and COPD Market Size by Type (2021-2026) & (US$ Million) Table 95. North America Drugs for Asthma and COPD Market Size by Type (2027-2032) & (US$ Million) Table 96. North America Drugs for Asthma and COPD Market Size by Application (2021-2026) & (US$ Million) Table 97. North America Drugs for Asthma and COPD Market Size by Application (2027-2032) & (US$ Million) Table 98. North America Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Drugs for Asthma and COPD Market Size by Country (2021-2026) Table 100. North America Drugs for Asthma and COPD Market Size by Country (2027-2032) Table 101. Europe Drugs for Asthma and COPD Market Size by Type (2021-2026) & (US$ Million) Table 102. Europe Drugs for Asthma and COPD Market Size by Type (2027-2032) & (US$ Million) Table 103. Europe Drugs for Asthma and COPD Market Size by Application (2021-2026) & (US$ Million) Table 104. Europe Drugs for Asthma and COPD Market Size by Application (2027-2032) & (US$ Million) Table 105. Europe Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Drugs for Asthma and COPD Market Size by Country (2021-2026) Table 107. Europe Drugs for Asthma and COPD Market Size by Country (2027-2032) Table 108. China Drugs for Asthma and COPD Market Size by Type (2021-2026) & (US$ Million) Table 109. China Drugs for Asthma and COPD Market Size by Type (2027-2032) & (US$ Million) Table 110. China Drugs for Asthma and COPD Market Size by Application (2021-2026) & (US$ Million) Table 111. China Drugs for Asthma and COPD Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Drugs for Asthma and COPD Market Size by Type (2021-2026) & (US$ Million) Table 113. Asia Drugs for Asthma and COPD Market Size by Type (2027-2032) & (US$ Million) Table 114. Asia Drugs for Asthma and COPD Market Size by Application (2021-2026) & (US$ Million) Table 115. Asia Drugs for Asthma and COPD Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Drugs for Asthma and COPD Market Size by Country (2021-2026) Table 118. Asia Drugs for Asthma and COPD Market Size by Country (2027-2032) Table 119. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Type (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Type (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Application (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Application (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2021-2026) Table 125. South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Drugs for Asthma and COPD Product Image Figure 2. Global Drugs for Asthma and COPD Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drugs for Asthma and COPD Market Share by Type: 2025 VS 2032 Figure 4. Inhalable & Nasal Spray Image Figure 5. Oral Image Figure 6. Others Image Figure 7. Global Drugs for Asthma and COPD Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Drugs for Asthma and COPD Market Share by Application: 2025 VS 2032 Figure 9. Asthma Image Figure 10. COPD Image Figure 11. Global Drugs for Asthma and COPD Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 13. Global Drugs for Asthma and COPD Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Drugs for Asthma and COPD Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Drugs for Asthma and COPD Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drugs for Asthma and COPD Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drugs for Asthma and COPD Revenue Market Share by Type (2021-2032) Figure 20. Global Drugs for Asthma and COPD Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drugs for Asthma and COPD Revenue Market Share by Application (2021-2032) Figure 22. North America Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 23. North America Drugs for Asthma and COPD Market Share by Type (2021-2032) Figure 24. North America Drugs for Asthma and COPD Market Share by Application (2021-2032) Figure 25. North America Drugs for Asthma and COPD Market Share by Country (2021-2032) Figure 26. United States Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 27. Canada Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 29. Europe Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 30. Europe Drugs for Asthma and COPD Market Share by Type (2021-2032) Figure 31. Europe Drugs for Asthma and COPD Market Share by Application (2021-2032) Figure 32. Europe Drugs for Asthma and COPD Market Share by Country (2021-2032) Figure 33. Germany Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 34. France Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 36. Italy Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 37. Russia Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 39. China Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 40. China Drugs for Asthma and COPD Market Share by Type (2021-2032) Figure 41. China Drugs for Asthma and COPD Market Share by Application (2021-2032) Figure 42. Asia Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 43. Asia Drugs for Asthma and COPD Market Share by Type (2021-2032) Figure 44. Asia Drugs for Asthma and COPD Market Share by Application (2021-2032) Figure 45. Asia Drugs for Asthma and COPD Market Share by Country (2021-2032) Figure 46. Japan Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 50. India Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 51. Australia Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Drugs for Asthma and COPD Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Drugs for Asthma and COPD Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Drugs for Asthma and COPD Market Share by Country (2021-2032) Figure 56. Brazil Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 61. UAE Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 63. Chile Drugs for Asthma and COPD Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Inhalable & Nasal Spray
  • Oral
  • Others
Applications
  • Asthma
  • COPD
Companies covered
  • GSK
  • Teva
  • Novartis
  • Merck
  • Mylan
  • Roche
  • AstraZeneca
  • Vertex
  • Sumitomo Dainippon
  • Chiesi
  • Boehringer Ingelheim
  • Beximco

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Inhalable & Nasal Spray
  5. 1.2.3 Oral
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Asthma
  10. 1.3.3 COPD
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Drugs for Asthma and COPD Growth Trends by Region
  13. 1.5.1 Global Drugs for Asthma and COPD Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Drugs for Asthma and COPD Market Size by Region (2021-2026)
  15. 1.5.3 Drugs for Asthma and COPD Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Drugs for Asthma and COPD Market Dynamics
  1. 2.1 Drugs for Asthma and COPD Industry Trends
  2. 2.2 Drugs for Asthma and COPD Industry Drivers
  3. 2.3 Drugs for Asthma and COPD Industry Opportunities and Challenges
  4. 2.4 Drugs for Asthma and COPD Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drugs for Asthma and COPD Revenue by Company (2021-2026)
  2. 3.2 Global Drugs for Asthma and COPD Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drugs for Asthma and COPD Key Company Head office and Area Served
  4. 3.4 Global Drugs for Asthma and COPD Company, Product Type & Application
  5. 3.5 Global Drugs for Asthma and COPD Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drugs for Asthma and COPD Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drugs for Asthma and COPD Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drugs for Asthma and COPD Tier 1, Tier 2, and Tier 3
4 Drugs for Asthma and COPD Market by Type
  1. 4.1 Global Drugs for Asthma and COPD Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drugs for Asthma and COPD Market Size by Type (2021-2032)
  3. 4.3 Global Drugs for Asthma and COPD Market Size Share by Type (2021-2032)
5 Drugs for Asthma and COPD Market by Application
  1. 5.1 Global Drugs for Asthma and COPD Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drugs for Asthma and COPD Market Size by Application (2021-2032)
  3. 5.3 Global Drugs for Asthma and COPD Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GSK Drugs for Asthma and COPD Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Drugs for Asthma and COPD Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Drugs for Asthma and COPD Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck Drugs for Asthma and COPD Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Mylan Drugs for Asthma and COPD Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Roche Drugs for Asthma and COPD Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AstraZeneca Drugs for Asthma and COPD Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Vertex
  44. 6.8.1 Vertex Company Information
  45. 6.8.2 Vertex Business Overview
  46. 6.8.3 Vertex Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Vertex Drugs for Asthma and COPD Product Portfolio
  48. 6.8.5 Vertex Recent Developments
  49. 6.9 Sumitomo Dainippon
  50. 6.9.1 Sumitomo Dainippon Company Information
  51. 6.9.2 Sumitomo Dainippon Business Overview
  52. 6.9.3 Sumitomo Dainippon Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sumitomo Dainippon Drugs for Asthma and COPD Product Portfolio
  54. 6.9.5 Sumitomo Dainippon Recent Developments
  55. 6.10 Chiesi
  56. 6.10.1 Chiesi Company Information
  57. 6.10.2 Chiesi Business Overview
  58. 6.10.3 Chiesi Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Chiesi Drugs for Asthma and COPD Product Portfolio
  60. 6.10.5 Chiesi Recent Developments
  61. 6.11 Boehringer Ingelheim
  62. 6.11.1 Boehringer Ingelheim Company Information
  63. 6.11.2 Boehringer Ingelheim Business Overview
  64. 6.11.3 Boehringer Ingelheim Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Boehringer Ingelheim Drugs for Asthma and COPD Product Portfolio
  66. 6.11.5 Boehringer Ingelheim Recent Developments
  67. 6.12 Beximco
  68. 6.12.1 Beximco Company Information
  69. 6.12.2 Beximco Business Overview
  70. 6.12.3 Beximco Drugs for Asthma and COPD Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Beximco Drugs for Asthma and COPD Product Portfolio
  72. 6.12.5 Beximco Recent Developments
7 North America
  1. 7.1 North America Drugs for Asthma and COPD Market Size (2021-2032)
  2. 7.2 North America Drugs for Asthma and COPD Market Size by Type
  3. 7.2.1 North America Drugs for Asthma and COPD Market Size by Type (2021-2026)
  4. 7.2.2 North America Drugs for Asthma and COPD Market Size by Type (2027-2032)
  5. 7.2.3 North America Drugs for Asthma and COPD Market Share by Type (2021-2032)
  6. 7.3 North America Drugs for Asthma and COPD Market Size by Application
  7. 7.3.1 North America Drugs for Asthma and COPD Market Size by Application (2021-2026)
  8. 7.3.2 North America Drugs for Asthma and COPD Market Size by Application (2027-2032)
  9. 7.3.3 North America Drugs for Asthma and COPD Market Share by Application (2021-2032)
  10. 7.4 North America Drugs for Asthma and COPD Market Size by Country
  11. 7.4.1 North America Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drugs for Asthma and COPD Market Size by Country (2021-2026)
  13. 7.4.3 North America Drugs for Asthma and COPD Market Size by Country (2027-2032)
  14. 7.4.4 North America Drugs for Asthma and COPD Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drugs for Asthma and COPD Market Size (2021-2032)
  2. 8.2 Europe Drugs for Asthma and COPD Market Size by Type
  3. 8.2.1 Europe Drugs for Asthma and COPD Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drugs for Asthma and COPD Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drugs for Asthma and COPD Market Share by Type (2021-2032)
  6. 8.3 Europe Drugs for Asthma and COPD Market Size by Application
  7. 8.3.1 Europe Drugs for Asthma and COPD Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drugs for Asthma and COPD Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drugs for Asthma and COPD Market Share by Application (2021-2032)
  10. 8.4 Europe Drugs for Asthma and COPD Market Size by Country
  11. 8.4.1 Europe Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drugs for Asthma and COPD Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drugs for Asthma and COPD Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drugs for Asthma and COPD Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drugs for Asthma and COPD Market Size (2021-2032)
  2. 9.2 China Drugs for Asthma and COPD Market Size by Type
  3. 9.2.1 China Drugs for Asthma and COPD Market Size by Type (2021-2026)
  4. 9.2.2 China Drugs for Asthma and COPD Market Size by Type (2027-2032)
  5. 9.2.3 China Drugs for Asthma and COPD Market Share by Type (2021-2032)
  6. 9.3 China Drugs for Asthma and COPD Market Size by Application
  7. 9.3.1 China Drugs for Asthma and COPD Market Size by Application (2021-2026)
  8. 9.3.2 China Drugs for Asthma and COPD Market Size by Application (2027-2032)
  9. 9.3.3 China Drugs for Asthma and COPD Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drugs for Asthma and COPD Market Size (2021-2032)
  2. 10.2 Asia Drugs for Asthma and COPD Market Size by Type
  3. 10.2.1 Asia Drugs for Asthma and COPD Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drugs for Asthma and COPD Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drugs for Asthma and COPD Market Share by Type (2021-2032)
  6. 10.3 Asia Drugs for Asthma and COPD Market Size by Application
  7. 10.3.1 Asia Drugs for Asthma and COPD Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drugs for Asthma and COPD Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drugs for Asthma and COPD Market Share by Application (2021-2032)
  10. 10.4 Asia Drugs for Asthma and COPD Market Size by Country
  11. 10.4.1 Asia Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drugs for Asthma and COPD Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drugs for Asthma and COPD Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drugs for Asthma and COPD Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drugs for Asthma and COPD Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drugs for Asthma and COPD Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drugs for Asthma and COPD Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drugs for Asthma and COPD Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst